Orthopedics Today
Welcome to the official website for Orthopedics Today, Orthopaedics Today Europe, and the publication ORTHOPEDICS. Here, you can find a comprehensive hub for all things related to orthopedics.
Outlet metrics
Global
#61003
United States
#21938
Health/Health
#505
Articles
-
1 day ago |
healio.com | Justin Cooper
Key takeaways:Misuse of over-the-counter anticholinergics, antihistamines and decongestants is an easily overlooked eye health risk factor. Optometrists should ask patients about their use of over-the-counter drugs. MINNEAPOLIS — Over-the-counter medications can have easily overlooked impacts on eye health if not used appropriately, according to a speaker at Optometry’s Meeting.
-
1 day ago |
healio.com | Justin Cooper
Key takeaways: The first-time pass rate for the first part of the NBEO exam fell from 76.9% in 2015 to 66.71% in 2024. The exam’s average first-time pass rate was the lowest of all comparable exams. MINNEAPOLIS — Students pass the National Board of Examiners in Optometry exam at a “notably lower” rate than similar exams in other areas of health care, according to a poster presented at Optometry’s Meeting. The findings come from research that Jeffrey L.
-
2 days ago |
healio.com | Justin Cooper
Key takeaways:The most common ocular manifestations of long COVID are conjunctivitis and dry eye. Optometrists can play an important role as part of a multidisciplinary management team. MINNEAPOLIS — Optometrists have an important part to play in the management of patients with long COVID, according to a speaker at Optometry’s Meeting.
-
2 days ago |
healio.com | Scott Buzby
Key takeaways: In the SOUL trial, Rybelsus reduced risk for heart events by 14% in patients with diabetes and prior heart and/or kidney disease. New analyses show change in HbA1c or body weight did not impact outcomes. CHICAGO — For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related events, with consistent findings in further analyses, according to new data from the SOUL trial.
-
2 days ago |
healio.com | Scott Buzby
ACC guidance permits use of modern medications as first-line therapy for obesity• An ACC panel states modern obesity medications may be considered as first-line therapy for treatment of obesity. • Patients should not be required to ‘try and fail’ lifestyle changes first, the panel wrote. A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may be considered as the first treatment for patients with obesity.
Orthopedics Today journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Contact Forms
Contact Form
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →